bupropion has been researched along with Dyskinesia, Medication-Induced in 9 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of the 266 recorded single bupropion overdoses, the most common symptoms were seizures (47." | 3.96 | Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity. ( Alsukaiti, WS; Calello, DP; Carpenter, J; Dunkley, C; Kazzi, Z; Kiernan, EA; Moran, TP; Murray, B; Rianprakaisang, T, 2020) |
| " Neonatal providers should be aware of maternal medications and prepare for possible adverse effects, particularly from common psychotropic exposures." | 1.62 | Why the Maternal Medication List Matters: Neonatal Toxicity From Combined Serotonergic Exposures. ( Brajcich, MR; Marks, J; Messer, RD; Murphy, ME; Palau, MA, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Murray, B | 1 |
| Carpenter, J | 1 |
| Dunkley, C | 1 |
| Moran, TP | 1 |
| Kiernan, EA | 1 |
| Rianprakaisang, T | 1 |
| Alsukaiti, WS | 1 |
| Calello, DP | 1 |
| Kazzi, Z | 1 |
| Brajcich, MR | 1 |
| Palau, MA | 1 |
| Messer, RD | 1 |
| Murphy, ME | 1 |
| Marks, J | 1 |
| Chen, PH | 1 |
| Chung, KH | 1 |
| Park, YM | 1 |
| Lee, HJ | 1 |
| Kang, SG | 1 |
| Choo, CS | 1 |
| Cho, JH | 1 |
| Ferentinos, P | 1 |
| Christodoulou, C | 1 |
| Rizos, E | 1 |
| Douzenis, A | 1 |
| Lykouras, L | 1 |
| de Graaf, L | 1 |
| Admiraal, P | 1 |
| van Puijenbroek, EP | 1 |
| Kohen, I | 1 |
| Sarcevic, A | 1 |
| Gardos, G | 1 |
| Szuba, MP | 1 |
| Leuchter, AF | 1 |
9 other studies available for bupropion and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; Cardiotoxicity; Dyskinesia, | 2020 |
Why the Maternal Medication List Matters: Neonatal Toxicity From Combined Serotonergic Exposures.
Topics: Antidepressive Agents; Bipolar Disorder; Brain Diseases; Bupropion; Drug Therapy, Combination; Dyski | 2021 |
Bupropion-Induced Dyskinesia in a Young Adult Patient With Bipolar Disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Dyskinesia, Drug-Induc | 2017 |
Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzamides; Benzyl Compounds; B | 2009 |
Mixed-type (limb-truncal and orofacial) bupropion-associated dyskinesia.
Topics: Bupropion; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Moveme | 2010 |
Ballism associated with bupropion use.
Topics: Adult; Bupropion; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Oxazepam | 2003 |
Mirtazapine in bupropion-induced dyskinesias: a case report.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Dyskinesia, D | 2006 |
Reversible dyskinesia during bupropion therapy.
Topics: Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Dose-Response Relations | 1997 |
Falling backward in two elderly patients taking bupropion.
Topics: Age Factors; Aged; Basal Ganglia Diseases; Bupropion; Depressive Disorder; Dyskinesia, Drug-Induced; | 1992 |